Human CMV pp65-LAMP mRNA-pulsed autologous DCs

BIOLOGICAL2 trials

Sponsors

Mustafa Khasraw, MBChB, MD, FRCP, FRACP, Annick Desjardins, MD

Conditions

Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastomaGlioblastoma Multiforme

Phase 2

DC Migration Study for Newly-Diagnosed GBM

CompletedNCT02366728

Mustafa Khasraw, MBChB, MD, FRCP, FRACPAstrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma +1

Start: 2015-10-12End: 2020-10-31Updated: 2023-06-08

DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab

Active, not recruitingNCT03688178

Annick Desjardins, MDGlioblastoma

Start: 2020-08-26End: 2026-03-31Updated: 2025-04-15

Related Papers

Reproducibility of outcomes in sequential trials using CMV-targeted dendritic cell vaccination for glioblastoma.

Journal of Clinical Oncology2022-06-0110 citations

CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA

Neuro-Oncology2021-11-022 citations

Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma

Clinical Cancer Research2020-07-2795 citations